FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:439-440 February 3, 2005 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Nguyen, H. Q. PubMed Citation

Varicella–zoster virus is the cause of both varicella (chickenpox) and herpes zoster (shingles). A live attenuated varicella vaccine was developed in Japan in 1974, and in 1995 it was approved for use in the United States. The policy of universal vaccination of susceptible children and adults has had a profound effect on the epidemiology of varicella. Its effect on the epidemiology of zoster remains to be seen, in part because of the long delay between primary infection with varicella–zoster virus and the subsequent occurrence of zoster.

Before varicella vaccine was introduced, chickenpox developed in approximately 4 million persons, most of . . . [Full Text of this Article]

Source Information

Dr. Vázquez is an assistant professor in the Department of Pediatrics and Dr. Shapiro is a professor in the Departments of Pediatrics and Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn.

This article has been cited by other articles:

• (2005). Varicella Deaths Decline Sharply After Universal Vaccination Adopted. JWatch Infect. Diseases 2005: 5-5 [Full Text]